THU0048 Pro-inflammatory il-17a-producing ccr6+ t helper memory cells change into anti-inflammatory cells with regulatory capacity upon exposure to active vitamin d. (12th June 2018)
- Record Type:
- Journal Article
- Title:
- THU0048 Pro-inflammatory il-17a-producing ccr6+ t helper memory cells change into anti-inflammatory cells with regulatory capacity upon exposure to active vitamin d. (12th June 2018)
- Main Title:
- THU0048 Pro-inflammatory il-17a-producing ccr6+ t helper memory cells change into anti-inflammatory cells with regulatory capacity upon exposure to active vitamin d
- Authors:
- Dankers, W.
Davelaar, N.
van Hamburg, J.P.
van de Peppel, J.
Colin, E.M.
Lubberts, E. - Abstract:
- Abstract : Background: In autoimmune diseases such as rheumatoid arthritis (RA), an important therapeutic goal is to normalise the imbalance between pro- and anti-inflammatory cells. In RA, especially pro-inflammatory CCR6 +T helper (Th) memory cells, characterised by IL-17A production and RORC expression, are elevated and more activated compared to healthy controls. Therefore, modulating these cells to become anti-inflammatory could contribute to restoring the immunological balance. Interestingly, the active vitamin D metabolite 1, 25(OH)2 D3 inhibits pro-inflammatory cytokine production by CCR6 +Th memory cells. Objectives: We investigated whether 1, 25(OH)2 D3 can induce an anti-inflammatory phenotype in these memory CCR6 +Th cells. Methods: CCR6 +Th memory cells, excluding Tregs, were sorted from treatment-naïve early RA patients or healthy controls and cultured with or without 1, 25(OH)2 D3 . Effects were analysed using microarray, RT-PCR, ELISA or flow cytometry. Functional properties were assessed via suppression and chemotaxis assays. Results: 1, 25(OH)2 D3 inhibits pro-inflammatory cytokines such as IL-17A, IL-17F and IL-22 in CCR6 +Th memory cells from both healthy controls and RA patients. This is accompanied by induction of anti-inflammatory factors, including IL-10 and CTLA4. Interestingly, these formerly pathogenic cells suppress proliferation of autologous CD3 +T cells, similar to classical Tregs. Importantly, the modulated memory cells still migrate towardsAbstract : Background: In autoimmune diseases such as rheumatoid arthritis (RA), an important therapeutic goal is to normalise the imbalance between pro- and anti-inflammatory cells. In RA, especially pro-inflammatory CCR6 +T helper (Th) memory cells, characterised by IL-17A production and RORC expression, are elevated and more activated compared to healthy controls. Therefore, modulating these cells to become anti-inflammatory could contribute to restoring the immunological balance. Interestingly, the active vitamin D metabolite 1, 25(OH)2 D3 inhibits pro-inflammatory cytokine production by CCR6 +Th memory cells. Objectives: We investigated whether 1, 25(OH)2 D3 can induce an anti-inflammatory phenotype in these memory CCR6 +Th cells. Methods: CCR6 +Th memory cells, excluding Tregs, were sorted from treatment-naïve early RA patients or healthy controls and cultured with or without 1, 25(OH)2 D3 . Effects were analysed using microarray, RT-PCR, ELISA or flow cytometry. Functional properties were assessed via suppression and chemotaxis assays. Results: 1, 25(OH)2 D3 inhibits pro-inflammatory cytokines such as IL-17A, IL-17F and IL-22 in CCR6 +Th memory cells from both healthy controls and RA patients. This is accompanied by induction of anti-inflammatory factors, including IL-10 and CTLA4. Interestingly, these formerly pathogenic cells suppress proliferation of autologous CD3 +T cells, similar to classical Tregs. Importantly, the modulated memory cells still migrate towards the site of inflammation, modelled by synovial fluid, and retain their suppressive capacity in this environment. Conclusions: Committed pro-inflammatory IL-17A-producing CCR6 +Th memory cells shift towards anti-inflammatory cells with functional regulatory capacities upon exposure to active vitamin D. This process can contribute to restoring the immunological balance and inhibiting synovial inflammation in RA. Disclosure of Interest: None declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 77(2018)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 77(2018)Supplement 2
- Issue Display:
- Volume 77, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 77
- Issue:
- 2
- Issue Sort Value:
- 2018-0077-0002-0000
- Page Start:
- 249
- Page End:
- 250
- Publication Date:
- 2018-06-12
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2018-eular.6997 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21364.xml